Global framework on essential health R&D

Lancet

Volumn 367, Issue 9522, 2006, Pages 1560-1561

  Chirac, Pierre ^a   Torreele, Els ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Suisse   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN DERIVATIVE; ARTESUNATE; CHLORPROGUANIL PLUS DAPSONE; FANSIDAR; MEFLOQUINE; MILTEFOSINE;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CHAGAS DISEASE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HELMINTHIASIS; INFECTION CONTROL; LEISHMANIASIS; MALARIA; MEDICAL RESEARCH; ONCHOCERCIASIS; PRIORITY JOURNAL; SCHISTOSOMIASIS; TUBERCULOSIS;

EID: 33646368910     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68672-8     Document Type: Note

References (13)

1. WHO. Global framework on essential health research and development (Jan 27, 2006). http://www.who.int/gb/ebwha/pdf_files/EB117/B117_R13-en.pdf (accessed April 26, 2006)
2. Trouiller P., and Olliaro P. Drug development output from 1975 to 1996: what output for tropical diseases?. Int J Infect Dis 3 (1999) 61-63
3. Pécoul B., Chirac P., Trouiller P., and Pinel J. Access to essential drugs: a lost battle?. JAMA 281 (1999) 361-367
4. Trouiller P., Olliaro P., Torreele E., Orbinski J., Laing R., and Ford N. Drug development for neglected diseases. Lancet 359 (2002) 2188-2194
5. Barral P. 30 ans de résultats de la recherche pharmaceutique dans le monde (1975-2004) (April 23, 2005). http://perso.club-internet.fr/barral_e (accessed April 26, 2006)
6. WHO. Dutch registration for artemotil injections (October, 2000). http://www.who.int/tdr/publications/tdrnews/news63/artemotil.htm (accessed April 26, 2006)
7. WHO. An artesunate + sulphadoxine/pyrimethamine combination blister package being developed jointly (February, 2001). http://www.who.int/tdr/publications/tdrnews/news64/blister.htm (accessed April 26, 2006)
8. DNDI. New hope for malaria patients in 2006 (Jan 5, 2006). http://www.researchappeal.org/dndi_pdf/New_Hope_for_Malaria_Patients_06.pdf (accessed April 26, 2006)
9. Novartis. Novartis accelerates production of live-saving malaria treatment Coartem (Jan 18, 2006). http://cws.huginonline.com/N/134323/PR/200601/1030389_5.html (accessed April 26, 2006)
10. WHO. Miltefosine, the story of a successful partnership: disease endemic country-TDR-pharmaceutical industry (Zentaris) (June, 2002). http://www.who.int/tdr/publications/tdrnews/news68/miltefosine-zentaris.htm (accessed April 26, 2006)
11. WHO. Lapdap: a new antimalarial for Africa (September, 2003). http://www.who.int/tdr/publications/tdrnews/news70/lapdap.htm (accessed April 26, 2006)
12. Moran M., Ropars A., Guzman J., Diaz J., and Garrison C. The new landscape of neglected diseases drug development. 4th edn. (2005), School of Economics and Wellcome Trust, London
13. WHO. Public health-innovation and intellectual property rights. Report of the commission on intellectual property rights, innovation and public heath (2005). http://www.who.int/intellectualproperty/en/ (accessed April 26, 2006)